Projected Income Statement: Imunon, Inc.

Forecast Balance Sheet: Imunon, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Change - - - - - - - -
Announcement Date 3/25/20 3/19/21 3/31/22 3/30/23 3/28/24 - - -
Estimates

Cash Flow Forecast: Imunon, Inc.

Fiscal Period: December 2024 2025 2026
CAPEX 1 - - -
Change - - -
Free Cash Flow (FCF) 1 -4 -33 -42.35
Change - 725% 28.33%
Announcement Date - - -
1USD in Million
Estimates

Forecast Financial Ratios: Imunon, Inc.

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

         
EBITDA Margin (%) - - - - - - - - -
EBIT Margin (%) - -4,113% -3,697.2% -4,201.4% -4,984.4% - - - -
EBT Margin (%) - -3,733.6% -4,665.8% -4,430.6% -7,493% - - - -
Net margin (%) - -3,370.4% -4,296.8% -4,153.8% -7,179.6% - - - -
FCF margin (%) - - - - - - - - -
FCF / Net Income (%) - - - - - - 19.53% 120.36% 114.87%

Profitability

         
ROA -27.9% -30.2% -30.48% -23.54% -26.39% -39.89% - - -
ROE -49.97% -95.15% -129.54% -55.83% -84.34% -91.37% - - -

Financial Health

         
Leverage (Debt/EBITDA) - - - - - - - - -
Debt / Free cash flow - - - - - - - - -

Capital Intensity

         
CAPEX / Current Assets (%) - - - - - - - - -
CAPEX / EBITDA (%) - - - - - - - - -
CAPEX / FCF (%) - - - - - - - - -

Items per share

         
Cash flow per share 1 - - - - - - - - -
Change - - - - - - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - -11.55 -10.05 -3.83 -5.03 -2.16 -1.7 -1.035 -0.7267
Change - - -12.99% -61.89% 31.33% -57.06% -21.3% -39.12% -29.79%
Nbr of stocks (in thousands) - 1,517 2,495 5,771 7,434 9,399 14,501 14,501 14,501
Announcement Date - 3/25/20 3/19/21 3/31/22 3/30/23 3/28/24 - - -
1USD
Estimates
2024 *2025 *
P/E ratio -0.52x -0.86x
PBR - -
EV / Sales - -
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.8910USD
Average target price
13.20USD
Spread / Average Target
+1,381.48%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. Financials Imunon, Inc.